Results 81 to 90 of about 11,803,234 (178)

Dose- and state-dependent enhancement of hippocampal CA1 pyramidal neuron excitability by GM1 ganglioside in male rats with cholinergic lesions. [PDF]

Sci Rep
Ashkavandi S, Moazedi AA, Semnanian S, Abdolahpour S, Gholami M.   +4 more
europepmc   +1 more source

A rare presentation of CASPR2-associated Morvan syndrome overlapping with GM1-positive AMSAN: a case report. [PDF]

Front Immunol
Wu Y, Tang X, Guan T, Xu J, Lv P, Dong Y.   +5 more
europepmc   +1 more source

Unmasking Probable Bickerstaff Brainstem Encephalitis in the Absence of Radiological and Cerebrospinal Fluid Clues. [PDF]

Cureus
Paul S, Srinivasan D, Pandurangan V.
europepmc   +1 more source

Deciphering the role of glycolipids as emerging therapeutic targets in EMT-driven cancer progression. [PDF]

Discov Oncol
Mukherjee A, Paul S, Datta C, Bhattacharjee A.   +3 more
europepmc   +1 more source

Hyperacute Guillain-Barré Syndrome Reaching Clinical Nadir Within 16 Hours. [PDF]

Intern Med
Matsubayashi T, Muramatsu R, Furuki M, Uchibori A, Obayashi M.   +4 more
europepmc   +1 more source

The influence of glutathione S-transferases M1 and M3 on the development of bladder cancer [PDF]

Problem: Cigarette smoking is the most important risk factor of transitional cell carcinoma of the urinary bladder. The effect of the glutathione S- transferases M1 (GSTM1) and M3 (GSTM3) on the influence of this risk factor was investigated.
Golka, Klaus, Bolt, Hermann M., Selinski, Silvia, Schmidt, Tobias   +3 more
core  

Diagnostic and therapeutic applications of the glycan biomarker H3N2b in GM1 Gangliosidosis. [PDF]

Mol Genet Metab
Kell P, Mishra S, D'Souza P, Tifft CJ, Dietzen DJ, Lasio LD, Carson JP, Hong X, Schiffmann R, Ledesma MD, Tayebi N, Dickson PI, Porter FD, Ory DS, Jiang X.   +14 more
europepmc   +1 more source

Gangliosidosis G M1 : a propósito de un caso clínico

, 2015
La gangliosidosis G M1 es una enfermedad de depósito lisosomal en la cual se acumula gangliósido-G M1 y otros compuestos galactoconjugados. La enfermedad es secundaria a la deficiencia de β -galactosidasa, con una afectación multiorgánica, en que ...
Eugenia Espinosa García, Yudy Andrea Ardila, Juan Pablo Londoño C., Olga Yaneth Echeverri Peña, Luis Alejandro Barrera A.   +4 more
core  

AAV9 Gene Therapy in Type II GM1 Gangliosidosis - A Phase 1-2 Trial. [PDF]

N Engl J Med
Lewis CJ, D'Souza P, Johnston JM, Acosta MT, Farmer C, Baker EH, Crowell A, Mojica Y, Ashraf S, Joseph L, Vézina G, Quezado Z, Yousef MH, Vardar Z, Shazeeb MS, Corti M, Blackwood M, Coleman K, Batista R, Thurm A, De Boever E, Gahl WA, Byrne BJ, Flotte TR, Jiang X, Gross AL, Keeler AM, Gray-Edwards H, Martin DR, Sena-Esteves M, Tifft CJ.   +30 more
europepmc   +1 more source

Monocyte-plasma cell communication characterizes treatment-associated peripheral immune remodeling in Guillain-Barré syndrome. [PDF]

Front Immunol
Kim S, Lee MA, Jang J, Kim M, Yoon BK, Fang S, Ahn HS, Hwang N.   +7 more
europepmc   +1 more source